APA (7th ed.) Citation

Singh-Phulgenda, S., Kumar, R., Dahal, P., Munir, A., Rashan, S., Chhajed, R., . . . Pandey, K. (2024). Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform. PLoS Neglected Tropical Diseases, 18(4), 1. https://doi.org/10.1371/journal.pntd.0011635

Chicago Style (17th ed.) Citation

Singh-Phulgenda, Sauman, et al. "Post-kala-azar Dermal Leishmaniasis (PKDL) Drug Efficacy Study Landscape: A Systematic Scoping Review of Clinical Trials and Observational Studies to Assess the Feasibility of Establishing an Individual Participant-level Data (IPD) Platform." PLoS Neglected Tropical Diseases 18, no. 4 (2024): 1. https://doi.org/10.1371/journal.pntd.0011635.

MLA (9th ed.) Citation

Singh-Phulgenda, Sauman, et al. "Post-kala-azar Dermal Leishmaniasis (PKDL) Drug Efficacy Study Landscape: A Systematic Scoping Review of Clinical Trials and Observational Studies to Assess the Feasibility of Establishing an Individual Participant-level Data (IPD) Platform." PLoS Neglected Tropical Diseases, vol. 18, no. 4, 2024, p. 1, https://doi.org/10.1371/journal.pntd.0011635.